There is significant morbidity associated with diabetes- and thyroid-related eye diseases. Many different ocular changes are associated with these endocrine disorders. Vitreous hemorrhage from diabetic neovascularization remains the leading cause of blindness, and several recent studies of the etiology of this disorder are of great importance. However, in addition, other research examined aspects of diabetic visual loss that are not blinding, and the prevention of such impairment became significant this past year. During this same interval, specific diagnostic criteria for thyroid ophthalmopathy were established and are included in this review; these findings will aid in future research and patient care.